Your browser doesn't support javascript.
loading
High mobility group box 1 protein in bronchoalveolar lavage fluid and correlation with other inflammatory markers in pulmonary diseases.
Suchankova, Magda; Durmanova, Vladimira; Tibenska, Elena; Tedlova, Eva; Majer, Ivan; Novosadova, Helena; Demian, Juraj; Tedla, Miroslav; Bucova, Maria.
Afiliação
  • Suchankova M; Institute of Immunology, Comenius University Faculty of Medicine, Bratislava, Slovakia.
  • Durmanova V; Institute of Immunology, Comenius University Faculty of Medicine, Bratislava, Slovakia.
  • Tibenska E; Medirex, Ltd., Bratislava, Slovakia.
  • Tedlova E; Department of Pneumology and Phthisiology, Comenius University Faculty of Medicine and University Hospital, Bratislava, Slovakia.
  • Majer I; Department of Pneumology and Phthisiology, Comenius University Faculty of Medicine and University Hospital, Bratislava, Slovakia.
  • Novosadova H; Department of Pneumology and Phthisiology, Comenius University Faculty of Medicine and University Hospital, Bratislava, Slovakia.
  • Demian J; Department of Pneumology and Phthisiology, Comenius University Faculty of Medicine and University Hospital, Bratislava, Slovakia.
  • Tedla M; Ist Department of Otorhinolaryngology, Comenius University Faculty of Medicine and University Hospital, Bratislava, Slovakia.
  • Bucova M; Institute of Immunology, Comenius University Faculty of Medicine, Bratislava, Slovakia.
Sarcoidosis Vasc Diffuse Lung Dis ; 35(3): 268-275, 2018.
Article em En | MEDLINE | ID: mdl-32476912
ABSTRACT

Objectives:

Analysis of new markers in bronchoalveolar lavage fluid (BALF) provides new insights into the immunopathogenesis and may be helpful in differential diagnosis of lung diseases. High mobility group box 1 protein (HMGB1) is a non-histone nuclear protein and its release into the extracellular environment may be associated with the inflammatory response. The aim of the study is the analysis of HMGB1 in BALF, correlations with other markers of inflammation and differences in extracellular HMGB1 levels in various lung diagnoses.

Methods:

The concentration of HMGB1 was tested by an Elisa test. We calculated correlations with other inflammatory markers (leukocytes, total protein, albumin, IgG, IgA, IgM, C3 complement component, alpha-2macroglobuline, CD3, CD4, CD8, TREM-1 and TREM-2) and specified HMGB1 level in various diagnoses.

Results:

A positive correlation was found between the level of HMGB1 and total protein levels (p=0.0001), albumin (p=0.0058), IgA (p=0.011), IgM (0.0439) and TREM-2 (p=0.0188). Conversely, a negative correlation was revealed between HMGB1 and TREM-1 (p=0.0009). HMGB1 level varied in different diagnoses the highest level was detected in QuantiFERON TB-positive subjects (median 30.2) and hypersensitivity pneumonitis (median 33.2), followed by pulmonary sarcoidosis (median 16.8) and idiopathic pulmonary fibrosis (median 8.8).

Conclusion:

HMGB1 correlates with other inflammatory markers tested in BALF. Its level varies in different lung diagnoses. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35 268-275).
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article